Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes

Journal of Clinical Gastroenterology

Volumn 43, Issue 6, 2009, Pages 569-573

  Cheng, Raymond ^a   Barton, James C ^c   Morrison, Elizabeth D ^a   Phatak, Pradyumna D ^d   Krawitt, Edward L ^e   Gordon, Stuart C ^f   Kowdley, Kris V ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VIRGINIA MASON MEDICAL CENTER   (United States)

^c SOUTHERN IRON DISORDERS CENTER   (United States)

^d UNIVERSITY OF ROCHESTER   (United States)

^e UNIVERSITY OF VERMONT   (United States)

^f HENRY FORD HOSPITAL   (United States)

Author keywords

C282Y; Compound heterozygote; Genotype; H63D; Hemochromatosis; HFE; Homozygote; Iron overload; Liver biopsy

Indexed keywords

FERRITIN; IRON;

ADULT; ARTICLE; CHRONIC HEPATITIS; COMPARATIVE STUDY; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; FATTY LIVER; FEMALE; FERRITIN BLOOD LEVEL; GENE EXPRESSION; GENE MUTATION; HEMOCHROMATOSIS; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IRON METABOLISM; IRON OVERLOAD; IRON STORAGE; KUPFFER CELL; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL;

ADULT; COHORT STUDIES; FEMALE; FERRITINS; GENOTYPE; HEMOCHROMATOSIS; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; IRON; LIVER; LIVER CIRRHOSIS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PHENOTYPE;

EID: 67651115587     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181919a33     Document Type: Article

References (14)

1. Ludwig J, Hashimoto E, Porayko MK, et al. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology. 1997; 112:883-888. (Pubitemid 27113814)
2. Feder JN. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13: 399-408.
3. Best LG, Harris PE, Spriggs EL. Hemochromatosis mutations C282Y and H63D in cis phase. Clin Genet. 2001;60: 68-72.
4. Mura C, Raguenes O, Ferec C. HFE mutations analysis in 811 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood. 1999;93: 2502-2505. (Pubitemid 29181181)
5. Bacon BR, Olynyk JK, Brunt EM, et al. HFE genotype in patients with hemochromatosis and other liver diseases. Ann Intern Med. 1999;130:953-962.
6. Beutler E. Genetic irony beyond hemochromatosis: clinical effects of HLA-H mutations. Lancet. 1997;349:296-297. (Pubitemid 27056816)
7. Tung BY, Emond MJ, Bronner MP, et al. Hepatitis C, iron status, and disease severity: relationship with HFE mutations. Gastroenterology. 2003;124:318-326. (Pubitemid 36169248)
8. Bonkovsky HL, Lambrecht RW, Shan Y. Iron as a co-morbid factor in nonhemochromatotic liver disease. Alcohol. 2003;30: 137-144. (Pubitemid 37040860)
9. Brunt EM, Olynyk JK, Britton BS, et al. Histological evaluation of iron in liver biopsies: relationship to HFE mutations. Am J Gastroenterol. 2000;95:1788-1793.
10. Morrison ED, Brandhagen DJ, Phatak PD, et al. Serum ferritin level predicts advanced hepatic fibrosis among US patients with phenotypic hemochromatosis. Ann Intern Med. 2003;138:627-633.
11. Hanson EH, Imperatore G, Burke W. HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology. Am J Epidemiol. 2001;154:193-206.
12. Phatak PD, Ryan DH, Cappuccio J, et al. Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients. Blood Cells Mol Dis. 2002;29:41-47.
13. Walsh A, Dixon JL, Ramm GA, et al. The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis. Clin Gastroenterol Hepatol. 2006;4: 1403-1410. (Pubitemid 44716739)
14. Adams PC. Is there a threshold of hepatic iron concentration that leads to cirrhosis in C282Y hemochromatosis? Am J Gastroenterol. 2001;96:567-569.